Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
    • Our Story
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025

Events, Funding & Breakthroughs, News

Gate2Brain will be participating in the Barcelona Deep Tech Summit 2025, a meeting point for companies, research centers, investors, and organizations driving science-based innovation and technology transfer. The event will take place from November 4 to 6 within the Smart City Expo – World Congress, at Fira Barcelona Gran Via.

This summit has become a key gathering for the deep tech ecosystem, where new collaborations are explored, breakthroughs are shared, and technology designed to create real impact is showcased. For Gate2Brain, it represents an opportunity to continue raising awareness around our technology and our mission: bringing medicines beyond biological barriers.

Where to find us

We will be located at:

  • Stand 3 – Xarxa i4Kids
    Hall 3, Fira Barcelona Gran Via

Pitch Session

Our CEO, Meritxell Teixidó, will be presenting in a session hosted by Banco Sabadell:

“Delivering therapies to the Central Nervous System”
Date: November 4
Time: 17:00
Location: Pitch Corner


Our Platform and Our Focus

At Gate2Brain, we are developing a shuttle peptide platform that enables the delivery of therapeutics — including small molecules, peptides, proteins, antibodies, and nanoparticles — to organs such as the brain, where therapeutic access is often limited. Our goal is to open new treatment opportunities for conditions where biological barriers represent a major challenge.

Our lead candidate, G2B-002, targets brain tumors, with a first indication in pediatric patients. This program has received Orphan Drug Designation from both the EMA (2024) and the FDA (2025), an important milestone on the path toward a future clinical trial.


We would like to thank Xarxa i4Kids / i4KIDS-EUROPE, Eurecat, and ACCIÓ for supporting our participation and for helping to strengthen an ecosystem where scientific knowledge and patient impact move forward together.

To schedule a meeting with our team: info@gate2brain.com

Gate2Brain — Bringing medicines beyond barriers.

November 3, 2025/by noticias
Tags: Barcelona DeepTech Summit
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2025/11/Barcelona-DeepTech-Summit.png 380 520 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2025-11-03 10:23:532025-11-03 10:28:38Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025November 3, 2025 - 10:23
  • Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery SolutionsOctober 15, 2025 - 12:56
  • Gate2Brain turns 5!July 9, 2025 - 18:07
  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery Solution...Gate2Brain’s CEO Highlighted Among 16 Women Entrepreneurs Shaping Future ...
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}